Kyntra Bio, Inc. · NASDAQ:KYNB
Armistice Capital, LLC reported a 9.35% stake in Kyntra Bio, Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Armistice Capital, LLC reported a 9.35% stake in Kyntra Bio, Inc., 378,000 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 9.35%
- Shares
- 378,000
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 9.35% | 378,000 |
| Steven Boyd | 9.35% | 378,000 |
Source
Related
- Kyntra Bio, Inc.
- Armistice Capital, LLC
- Kyntra Bio, Inc. shareholders
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2026
- Schedule 13G/A · Armistice Capital, LLC · Feb 17, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2025
- Form 4 · Wettig Thane · Sep 9, 2026
- Form 4 · DeLucia David · Sep 9, 2026
- Form 4 · Wettig Thane · Jun 9, 2026
- Form 4 · DeLucia David · Jun 9, 2026
- Form 4/A · Wettig Thane · May 19, 2026